Exact Sciences Licenses Invader Technology from Hologic | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences said Tuesday that it has licensed worldwide rights to Hologic's Invader plus and real-time Invader detection chemistries for colorectal screening applications.

Terms of the agreement are not being disclosed by the firms.

The Invader chemistry was developed by Hologic subsidiary Third Wave Technologies, which formerly was run by Exact Sciences' current President and CEO Kevin Conroy, before it was acquired by Hologic for $580 million in July 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.